Rhythm Pharmaceuticals Inc (RYTM)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Rhythm Pharmaceuticals Inc-Aktie (RYTM)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	7.15% 25.97	24.23	22.50	19.22	11.47
Cost Of Revenue	13.18% 2.807	3.233	2.412	2.236	1.421
Gross Profit	10.28% 23.16	21.00	20.09	16.98	10.05
Operating Expenses	161.86% 163.05	62.27	64.05	63.59	62.58
Interest Income/Expense	4.51% 4.755	4.55	3.149	3.303	3.061
Benefits Costs and Expenses	154.36% 167.04	65.67	66.30	65.83	63.65
Costs And Expenses	153.22% 165.85	65.50	66.46	65.83	64.00
Operating Income/Loss	239.00% -139.89	-41.27	-43.95	-46.60	-52.53
Nonoperating Income/Loss	588.95% -1.185	-0.172	0.158	-0.099	0.352
Income/Loss From Continuing Operations Before Tax	240.45% -141.07	-41.44	-43.80	-46.70	-52.18
Income Tax Expense/Benefit	53.06% 0.30	0.196	0.368	-	-
Income/Loss From Continuing Operations After Tax	239.57% -141.37	-41.63	-44.16	-46.70	-52.18
Net Income/Loss	239.57% -141.37	-41.63	-44.16	-46.70	-52.18
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	11,503% 60.14	0.5183	57.87	56.87	56.71
Basic Earnings Per Share	235.71% -2.35	-0.70	-0.76	-0.82	-0.92
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$18.98

3.66%

INCY

$76.97

1.45%

MRNA

$39.51

7.22%

UTHR

$359.21

1.11%

BGNE

$187.69

0.81%

BNTX

$101.87

2.16%